Role of Interleukin-10 Promoter Polymorphisms in Oral Cancer Susceptibility: A Meta-Analysis

References

• Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS, et al. The growing burden of cancer in India: epidemiology and social context. Lancet Oncol. 2014;15(6):e205-12–e212. doi:10.1016/S1470-2045(14)70115-9.
   PubMed Web of Science ®Google Scholar
• Ashcraft KA, Boss MK, Tovmasyan A, Roy Choudhury K, Fontanella AN, Young KH, et al. Novel manganese-porphyrin superoxide dismutase-mimetic widens the therapeutic margin in a preclinical head and neck cancer model. Int J Radiat Oncol Biol Phys. 2015;93(4):892–900. doi:10.1016/j.ijrobp.2015.07.2283.
   PubMed Web of Science ®Google Scholar
• Liao G, Wang Y, Zhou YQ, Li TW, Zeng DQ, Zeng X, et al. Host genetic susceptibility to oral cancer: evidence from meta-analyses and pooled analyses. Oral Dis. 2014;20(7):644–649. doi:10.1111/odi.12184.
   PubMed Web of Science ®Google Scholar
• McDowell JD. An overview of epidemiology and common risk factors for oral squamous cell carcinoma. Otolaryngol Clin North Am. 2006;39(2):277–294. doi:10.1016/j.otc.2005.11.012.
   PubMed Web of Science ®Google Scholar
• Jeng JH, Chang MC, Hahn LJ. Role of areca nut in betel quid-associated chemical carcinogenesis: current awareness and future perspectives. Oral Oncol. 2001;37(6):477–492. doi:10.1016/s1368-8375(01)00003-3.
   PubMed Web of Science ®Google Scholar
• Cheng RH, Wang YP, Chang JY, Pan YH, Chang MC, Jeng JH. Genetic susceptibility and protein expression of extracellular matrix turnover-related genes in oral submucous fibrosis. IJMS. 2020;21(21):8104. doi:10.3390/ijms21218104.
   Google Scholar
• Mannino MH, Zhu Z, Xiao H, Bai Q, Wakefield MR, Fang Y. The paradoxical role of IL-10 in immunity and cancer. Cancer Lett. 2015;367(2):103–107. doi:10.1016/j.canlet.2015.07.009.
   PubMed Web of Science ®Google Scholar
• Mohamed HT, El-Husseiny N, El-Ghonaimy EA, Ibrahim SA, Bazzi ZA, Cavallo-Medved D, et al. IL-10 correlates with the expression of carboxypeptidase B2 and lymphovascular invasion in inflammatory breast cancer: the potential role of tumor infiltrated macrophages. Curr Probl Cancer. 2018;42(2):215–230. doi:10.1016/j.currproblcancer.2018.01.009.
   PubMed Web of Science ®Google Scholar
• Berti FCB, Pereira APL, Cebinelli GCM, Trugilo KP, Brajão de Oliveira K. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma. Cytokine Growth Factor Rev. 2017;34:1–13. doi:10.1016/j.cytogfr.2017.03.002.
   PubMed Web of Science ®Google Scholar
• Li L, Sun P, Zhang C, Li Z, Zhou W. MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10. Biochimie. 2018;150:23–30. doi:10.1016/j.biochi.2018.04.016.
   PubMed Web of Science ®Google Scholar
• Cunha LL, Morari EC, Nonogaki S, Marcello MA, Soares FA, Vassallo J, et al. Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancer. Cancer Immunol Immunother. 2017;66(2):141–148. doi:10.1007/s00262-016-1924-4.
   PubMed Web of Science ®Google Scholar
• Lane D, Matte I, Garde-Granger P, Bessette P, Piché A. Ascites IL-10 promotes ovarian cancer cell migration. Cancer Microenviron. 2018;11(2–3):115–124. doi:10.1007/s12307-018-0215-3.
   PubMed Web of Science ®Google Scholar
• Arantes DA, Costa NL, Mendonça EF, Silva TA, Batista AC. Overexpression of immunosuppressive cytokines is associated with poorer clinical stage of oral squamous cell carcinoma. Arch Oral Biol. 2016;61:28–35. doi:10.1016/j.archoralbio.2015.10.013.
   PubMed Web of Science ®Google Scholar
• Avradopoulos K, Mehta S, Blackinton D, Wanebo HJ. Interleukin-10 as a possible mediator of immunosuppressive effect in patients with squamous cell carcinoma of the head and neck. Ann Surg Oncol. 1997;4(2):184–190. doi:10.1007/BF02303803.
   PubMed Web of Science ®Google Scholar
• Karcher J, Reisser C, Daniel V, Herold-Mende C. Cytokine expression of transforming growth factor-beta2 and interleukin-10 in squamous cell carcinomas of the head and neck. Comparison of tissue expression and serum levels. Hno. 1999;47(10):879–884. doi:10.1007/s001060050528.
   PubMed Web of Science ®Google Scholar
• Fujieda S, Sunaga H, Tsuzuki H, Fan GK, Saito H. IL-10 expression is associated with the expression of platelet-derived endothelial cell growth factor and prognosis in oral and oropharyngeal carcinoma. Cancer Lett. 1999;136(1):1–9. doi:10.1016/s0304-3835(98)00281-x.
   PubMed Web of Science ®Google Scholar
• Guo C, Wen L, Song JK, Zeng WJ, Dan C, Niu YM, et al. Significant association between interleukin-10 gene polymorphisms and cervical cancer risk: a meta-analysis. Oncotarget. 2018;9(15):12365–12375. doi:10.18632/oncotarget.24193.
   PubMedGoogle Scholar
• Goud EVSS, Malleedi S, Ramanathan A, Wong GR, Hwei Ern BT, Yean GY, et al. Association of interleukin-10 genotypes and oral cancer susceptibility in selected Malaysian population: a case–control study. Asian Pac J Cancer Prev. 2019;20(3):935–941. doi:10.31557/APJCP.2019.20.3.935.
   PubMedGoogle Scholar
• Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med. 2003;349(23):2201–2210. doi:10.1056/NEJMoa022060.
   PubMed Web of Science ®Google Scholar
• Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997;24(1):1–8. doi:10.1111/j.1365-2370.1997.tb00001.x.
   PubMedGoogle Scholar
• Horvat V, Mandić S, Marczi S, Mrčela M, Galić J. Association of IL-1β and IL-10 polymorphisms with prostate cancer risk and grade of disease in Eastern Croatian population. Coll Antropol. 2015;39(2):393–400.
   PubMedGoogle Scholar
• Zhang YM, Mao YM, Sun YX. Genetic polymorphisms of IL-6 and IL-10 genes correlate with lung cancer in never-smoking Han population in China. Int J Clin Exp Med. 2015;8(1):1051–1058.
   PubMed Web of Science ®Google Scholar
• de Oliveira JG, Rossi AF, Nizato DM, Cadamuro AC, Jorge YC, Valsechi MC, et al. Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer. Tumour Biol. 2015;36(12):9159–9170. doi:10.1007/s13277-015-3593-x.
   PubMedGoogle Scholar
• Yang Y, Fa X. Role of IL-10 gene polymorphisms on the susceptibility for esophageal cancer and its association with environmental factors. Int J Clin Exp Pathol. 2015;8(8):9580–9585.
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123-30–e130.
   PubMedGoogle Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25(9):603–605. doi:10.1007/s10654-010-9491-z.
   PubMed Web of Science ®Google Scholar
• Andrews J, Guyatt G, Oxman AD, Alderson P, Dahm P, Falck-Ytter Y, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66(7):719–725. doi:10.1016/j.jclinepi.2012.03.013.
   PubMed Web of Science ®Google Scholar
• Verhagen M, van der Meij A, van Deurzen PA, Janzing JG, Arias-Vásquez A, Buitelaar JK, et al. Meta-analysis of the BDNF Val66Met polymorphism in major depressive disorder: effects of gender and ethnicity. Mol Psychiatry. 2010;15(3):260–271. doi:10.1038/mp.2008.109.
   PubMed Web of Science ®Google Scholar
• Vairaktaris E, Yapijakis C, Serefoglou Z, Derka S, Vassiliou S, Nkenke E, et al. The interleukin-10 (-1082A/G) polymorphism is strongly associated with increased risk for oral squamous cell carcinoma. Anticancer Res. 2008;28(1a):309–314.
   PubMed Web of Science ®Google Scholar
• Yao JG, Gao LB, Liu YG, Li J, Pang GF. Genetic variation in interleukin-10 gene and risk of oral cancer. Clin Chim Acta. 2008;388(1–2):84–88. doi:10.1016/j.cca.2007.10.012.
   PubMed Web of Science ®Google Scholar
• Tsai CW, Chang WS, Lin KC, Shih LC, Tsai MH, Hsiao CL, et al. Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan. Anticancer Res. 2014;34(7):3731–3737.
   PubMed Web of Science ®Google Scholar
• Hsu HJ, Yang YH, Shieh TY, Chen CH, Kao YH, Yang CF, et al. TGF-β1 and IL-10 single nucleotide polymorphisms as risk factors for oral cancer in Taiwanese. Kaohsiung J Med Sci. 2015;31(3):123–129. doi:10.1016/j.kjms.2014.12.003.
   PubMed Web of Science ®Google Scholar
• Hussain SR, Ahmad MK, Mahdi AA, Naqvi H, Ahmad MW, Srivastava S, et al. Association of Interleukin-10 (A1082G) gene polymorphism with Oral squamous cell carcinoma in north Indian population. J Genet. 2016;95(2):249–255. doi:10.1007/s12041-016-0626-1.
   PubMed Web of Science ®Google Scholar
• Sharma U, Singhal P, Bandil K, Kumar A, Bose S, Ahuja P, et al. Genetic variations of IL-10: identification of novel variations and evaluation of the impact of the SNPs/haplotype in the promoter region with the progression of Oral Squamous Cell Carcinoma in Indian population. Cytokine. 2018;103:99–108. doi:10.1016/j.cyto.2017.09.016.
   PubMed Web of Science ®Google Scholar
• Singh PK, Ahmad MK, Kumar V, Gupta R, Kohli M, Jain A, et al. Genetic polymorphism of interleukin-10 (-A592C) among oral cancer with squamous cell carcinoma. Arch Oral Biol. 2017;77:18–22. doi:10.1016/j.archoralbio.2016.12.011.
   PubMed Web of Science ®Google Scholar
• Fortis C, Foppoli M, Gianotti L, Galli L, Citterio G, Consogno G, et al. Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett. 1996;104(1):1–5. doi:10.1016/0304-3835(96)04213-9.
   PubMed Web of Science ®Google Scholar
• Li YF, Yang PZ, Li HF. Functional polymorphisms in the IL-10 gene with susceptibility to esophageal, nasopharyngeal, and oral cancers. Cancer Biomark. 2016;16(4):641–651. doi:10.3233/CBM-160606.
   PubMed Web of Science ®Google Scholar
• You Y, Du X, Fan M, Wu B, Xie C. Association between IL-10 polymorphisms (-1082A/G, -592A/C and -819T/C) and oral cancer risk. Int J Clin Exp Med. 2015;8(8):13187–13194.
   PubMed Web of Science ®Google Scholar
• Rezaei F, Doulatparast D, Sadeghi M. Common polymorphisms of Interleukin-10 (-1082A/G, -592A/C, and -819C/T) in oral cancers: an updated meta-analysis. J Interferon Cytokine Res. 2020;40(7):357–369. doi:10.1089/jir.2019.0145.
   PubMed Web of Science ®Google Scholar
• Wang P, An J, Zhu Y, Wan X, Zhang H, Xi S, et al. Association of three promoter polymorphisms in interleukin-10 gene with cancer susceptibility in the Chinese population: a meta-analysis. Oncotarget. 2017;8(37):62382–62399. doi:10.18632/oncotarget.18220.
   PubMedGoogle Scholar
• Huang W, Song J, Jia XW, Chen YX, Shi J, Jiang X. Interleukin-10 rs1800896 polymorphism is associated with increased head and neck cancer risk but not associated with its clinical stages. Oncotarget. 2017;8(23):37217–37224. doi:10.18632/oncotarget.16660.
   PubMedGoogle Scholar
• Niu YM, Du XY, Cai HX, Zhang C, Yuan RX, Zeng XT, et al. Increased risks between Interleukin-10 gene polymorphisms and haplotype and head and neck cancer: a meta-analysis. Sci Rep. 2015;5(1):17149. doi:10.1038/srep17149.
   PubMedGoogle Scholar